Cargando…
Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate Cancer
Over a century ago, low-dose-rate (LDR) brachytherapy was introduced to treat prostate cancer (PCa). Since then, it has been widely applied worldwide, including in East Asia. LDR brachytherapy has been performed in 88 institutes in Japan. Beneficial clinical outcomes of LDR brachytherapy for interme...
Autores principales: | Kato, Manabu, Higashi, Shinichiro, Sugino, Yusuke, Kajiwara, Shinya, Tanaka, Shiori, Kitano, Goshi, Yamashita, Yasuhumi, Ogura, Yuji, Tachibana, Hiroyuki, Kojima, Takahiro, Inoue, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670683/ https://www.ncbi.nlm.nih.gov/pubmed/37999133 http://dx.doi.org/10.3390/curroncol30110713 |
Ejemplares similares
-
Prognostic Effect of Preoperative Psoas Muscle Hounsfield Unit at Radical Cystectomy for Bladder Cancer
por: Sugino, Yusuke, et al.
Publicado: (2021) -
Dramatic response to pembrolizumab after pseudoprogression in a patient with advanced metastatic castration‐resistant prostate cancer
por: Kageyama, Takumi, et al.
Publicado: (2022) -
Pulmonary Metastases After Low-Dose-Rate Brachytherapy for Localized Prostate Cancer
por: Kido, Masahito, et al.
Publicado: (2014) -
Polish Brachytherapy Society – Presidential opening: Chasing Brachytherapy
por: Wojcieszek, Piotr
Publicado: (2019) -
Roles of the PARP Inhibitor in BRCA1 and BRCA2 Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor Microenvironment
por: Inoue, Takahiro, et al.
Publicado: (2023)